EHP Funds Inc’s Aerie Pharmaceuticals AERI Stock Holding History

EHP Funds Inc’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-275,924	Closed	-$4.17M	–	428
2022 Q3	$4.17M	Buy	+275,924	New	+$3.21M	0.85%	34

EHP Funds Inc's AERI Position: Q4 2022 in Review

EHP Funds Inc sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 275,924 shares — an estimated $4.17M sold.

EHP Funds Inc first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $4.17M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

EHP Funds Inc reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
EHP Funds Inc sold 275,924 Aerie Pharmaceuticals shares in Q4 2022, an estimated $4.17M.
EHP Funds Inc first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
EHP Funds Inc's Aerie Pharmaceuticals position peaked at $4.17M in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on EHP Funds Inc's 13F filing for Q4 2022, filed 14 Feb 2023.